Erratum to: PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment

被引：0

作者：

Dimitrios Mathios

Jacob Ruzevick

Christopher M. Jackson

Haiying Xu

Sagar R. Shah

Janis M. Taube

Peter C. Burger

Edward F. McCarthy

Alfredo Quinones-Hinojosa

Drew M. Pardoll

Michael Lim

机构：

[1] The Johns Hopkins University School of Medicine,Department of Neurosurgery

[2] The Johns Hopkins University School of Medicine,Department of Dermatology

[3] The Johns Hopkins University School of Medicine,Department of Biomedical Engineering

[4] The Johns Hopkins University School of Medicine,Department of Pathology

[5] The Johns Hopkins University School of Medicine,Department of Oncology

[6] The Johns Hopkins University School of Medicine,Department of Medicine

[7] Johns Hopkins Hospital,Department of Neurosurgery

来源：

Journal of Neuro-Oncology | 2016年 / 128卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：183 / 183

共 50 条

[31] Immune Checkpoint (PD-1, PD-L1, PD-L2, and CTLA-4) Expression in Plasma Cell Myeloma [J].

Lee, Min Young ;

Park, Chan-jeoung ;

Cho, Young-Uk ;

You, Eunkyoung ;

Jang, Seongsoo ;

Lee, Jung-Hee ;

Hong, Jung Yong ;

Yoon, Dok Hyun ;

Suh, Cheolwon .

BLOOD, 2017, 130

[32] Gene expression and soluble protein level of PD-1 and its ligands (PD-L1 and PD-L2) in endometrial cancer [J].

Yusof, Mohd Nazzary Mamat ;

Chew, Kah Teik ;

Kampan, Nirmala Chandralega ;

Hafizz, Abdul Muzhill Hannaan Abdul ;

Shafiee, Mohamad Nasir .

PLOS ONE, 2025, 20 (03)

[33] Clinical Value of the PD-1/PD-L1/PD-L2 Pathway in Patients Suffering from Endometriosis [J].

Suszczyk, Dorota ;

Skiba, Wiktoria ;

Zardzewialy, Witold ;

Pawlowska, Anna ;

Wlodarczyk, Karolina ;

Polak, Grzegorz ;

Tarkowski, Rafal ;

Wertel, Iwona .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (19)

[34] PD-1 is conserved from sharks to humans: new insights into PD-1, PD-L1, PD-L2, and SHP-2 evolution [J].

Kondo, Ryohei ;

Kondo, Kohei ;

Nabeshima, Kei ;

Nishikimi, Akihiko ;

Ishida, Yasumasa ;

Shigeoka, Toshiaki ;

Dijkstra, Johannes M. .

FRONTIERS IN IMMUNOLOGY, 2025, 16

[35] High-affinity PD-1 molecules deliver improved interaction with PD-L1 and PD-L2 [J].

Li, Yanyan ;

Liang, Zhaoduan ;

Tian, Ye ;

Cai, Wenxuan ;

Weng, Zhiming ;

Chen, Lin ;

Zhang, Huanling ;

Bao, Yifeng ;

Zheng, Hongjun ;

Zeng, Sihai ;

Bei, Chunhua ;

Li, Yi .

CANCER SCIENCE, 2018, 109 (08) :2435-2445

[36] Prognostic value of PD-1, PD-L1 and PD-L2 deserves attention in head and neck cancer [J].

Jiang, Siqing ;

Li, Xin ;

Huang, Lihua ;

Xu, Zhensheng ;

Lin, Jinguan .

FRONTIERS IN IMMUNOLOGY, 2022, 13

[37] Structural Biology of the Immune Checkpoint Receptor PD-1 and Its Ligands PD-L1/PD-L2 [J].

Zak, Krzysztof M. ;

Grudnik, Przemyslaw ;

Magiera, Katarzyna ;

Domling, Alexander ;

Dubin, Grzegorz ;

Holak, Tad A. .

STRUCTURE, 2017, 25 (08) :1163-1174

[38] The role of antagonists of the PD-1: PD-L1/PD-L2 axis in head and neck cancer treatment [J].

Pai, Sara I. ;

Zandberg, Dan P. ;

Strome, Scott E. .

ORAL ONCOLOGY, 2016, 61 :152-158

[39] Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade [J].

Bai, Jie ;

Gao, Zhitao ;

Li, Xiang ;

Dong, Liang ;

Han, Weidong ;

Nie, Jing .

ONCOTARGET, 2017, 8 (66) :110693-110707

[40] Regulation of Immunity in Clear Cell Renal Carcinoma: Role of PD-1, PD-L1, and PD-L2 [J].

Spirina, Liudmila ;

Yurmazov, Zahar ;

Usynin, Evgeny ;

Kondakova, Irina ;

Ladutko, Ekaterine ;

Choynzonov, Evgeny .

CURRENT ISSUES IN MOLECULAR BIOLOGY, 2021, 43 (02) :1072-1080

← 1 2 3 4 5 →